Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 34Colonic Neoplasms 18Rectal Neoplasms 14Pancreatic Neoplasms 8Esophageal Neoplasms 7Adenomatous Polyposis Coli 7Liver Neoplasms 5Carcinoma, Hepatocellular 4Neoplasm Metastasis 3Turcot syndrome 2Thymoma 2Neoplasms 2Lung Neoplasms 2Locally Advanced Rectal Cancer 2Hand-Foot Syndrome 2Gastrointestinal Neoplasms 2Esophageal Squamous Cell Carcinoma 2Breast Neoplasms 2Adenocarcinoma Of Esophagus 2Thrombocytosis 1Stomach Neoplasms 1Sarcoma 1Recurrence 1Prostatic Neoplasms 1Primary Myelofibrosis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Precancerous Conditions 1Polyps 1Pancreatic Cancer Metastatic 1Pain, Postoperative 1

Interventions

Gemcitabine 40Cisplatin 24Capecitabine 21Fluorouracil 19Oxaliplatin 17Leucovorin 14pembrolizumab 9Irinotecan 8Radiotherapy 7Erlotinib Hydrochloride 7durvalumab 6Sorafenib 4Photochemotherapy 4Magnetic Resonance Spectroscopy 4Carboplatin 4trametinib 3Trastuzumab 3Radiofrequency Ablation 3Long-Term Synaptic Depression 3Interleukin-12 Subunit p35 3Filgrastim 3Drug Therapy 3Dihematoporphyrin Ether 3Dexamethasone 3Cholangiopancreatography, Endoscopic Retrograde 3Chemotherapy, Adjuvant 3trifluridine tipiracil drug combination 2tivozanib 2tislelizumab 2spartalizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Bile Duct Neoplasms × Celecoxib × Gastrointestinal × Clear all
NCT01111591 2016-10-28

Cyclooxygenase-2 Inhibitor for Adjuvant Anticancer Effect in Patients With Biliary-pancreas Cancer

Seoul National University Hospital

Phase 4 Unknown
220 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡